BIOCRYST PHARMACEUTICALS INC (BCRX)
BIOCRYST PHARMACEUTICALS INC (BCRX) has a 87-report earnings history dating back to Oct 20, 2004. Its average absolute post-earnings move is ±7.44%, and 39.1% of those reactions were positive. Its largest post-earnings gain was +23.52% (May 05, 2025) and its largest decline was -40.41% (Nov 08, 2012). The next earnings report is predicted for 2026-08-04 (approximate).
Earnings reactions
How BCRX moved on each past earnings report.
Earnings Impact
Total Earnings
87
Avg Abs. Movement
±7.44%
Positive %
39.1%
Negative %
60.9%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| May 06, 2026 | ☀ PRE | -2.21% | open_in_new |
| Feb 26, 2026 | ☀ PRE | +4.64% | open_in_new |
| Nov 03, 2025 | ☀ PRE | -6.28% | open_in_new |
| Aug 04, 2025 | ☀ PRE | +9.81% | open_in_new |
Earnings Count
87
Total earnings in dataset
Avg Abs. Movement
±7.44%
Avg % price change on earnings
Institutional ownership
Holdings as of Mar 31, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 8-K | 20260629 | open_in_new SEC.gov |
| 4 | 20260615 | open_in_new SEC.gov |
| 4 | 20260615 | open_in_new SEC.gov |
| 4 | 20260615 | open_in_new SEC.gov |
| 4 | 20260615 | open_in_new SEC.gov |
| 4 | 20260615 | open_in_new SEC.gov |
| 4 | 20260615 | open_in_new SEC.gov |
| 4 | 20260615 | open_in_new SEC.gov |
| 4 | 20260615 | open_in_new SEC.gov |
| 4 | 20260615 | open_in_new SEC.gov |
Frequently asked about BCRX earnings
When does BIOCRYST PHARMACEUTICALS INC report earnings next? expand_more
BIOCRYST PHARMACEUTICALS INC (BCRX)'s next earnings date is approximate for 2026-08-04. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does BCRX stock move after earnings? expand_more
Over 87 reports, BCRX has moved an average of ±7.44% the session after earnings, closing higher 39.1% of the time.
What was BCRX's biggest post-earnings move? expand_more
BCRX's largest post-earnings gain on record was +23.52% on May 05, 2025, and its largest decline was -40.41% on Nov 08, 2012.
Where can I find BIOCRYST PHARMACEUTICALS INC's SEC filings? expand_more
All of BIOCRYST PHARMACEUTICALS INC's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right
Reporting around the same time
- Aligos Therapeutics, Inc. Common Stock (ALGS) earnings 2026-08-05
- Allegiant Travel CO (ALGT) earnings 2026-08-03
- AbCellera Biologics Inc. Common Shares (ABCL) earnings 2026-08-05
- Airbnb (ABNB) earnings 2026-08-05
- Arbutus Biopharma Corp (ABUS) earnings 2026-08-03
- Arcosa, Inc. (ACA) earnings 2026-08-04
- ACADIA PHARMACEUTICALS INC (ACAD) earnings 2026-08-05
- ACCO BRANDS Corp (ACCO) earnings 2026-08-04